These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 37692967)

  • 1. Unlocking therapeutic potential: integration of drug repurposing and immunotherapy for various disease targeting.
    Pawar VA; Tyagi A; Verma C; Sharma KP; Ansari S; Mani I; Srivastva SK; Shukla PK; Kumar A; Kumar V
    Am J Transl Res; 2023; 15(8):4984-5006. PubMed ID: 37692967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing anticancer drugs for the management of COVID-19.
    El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
    Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
    Ng YL; Salim CK; Chu JJH
    Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing old molecules for new indications: Defining pillars of success from lessons in the past.
    Mittal N; Mittal R
    Eur J Pharmacol; 2021 Dec; 912():174569. PubMed ID: 34653378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposed drugs in metabolic disorders.
    Finsterer J; Frank M
    Curr Top Med Chem; 2013; 13(18):2386-94. PubMed ID: 24059459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs.
    Parisi D; Adasme MF; Sveshnikova A; Bolz SN; Moreau Y; Schroeder M
    Comput Struct Biotechnol J; 2020; 18():1043-1055. PubMed ID: 32419905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancements in Drug Repurposing: Examples in Psychiatric Medications.
    Okuyama R
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-based stage-specific drug repurposing for Alzheimer's disease.
    Savva K; Zachariou M; Bourdakou MM; Dietis N; Spyrou GM
    Comput Struct Biotechnol J; 2022; 20():1427-1438. PubMed ID: 35386099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filling the gap in CNS drug development: evaluation of the role of drug repurposing.
    Caban A; Pisarczyk K; Kopacz K; Kapuśniak A; Toumi M; Rémuzat C; Kornfeld A
    J Mark Access Health Policy; 2017; 5(1):1299833. PubMed ID: 28473889
    [No Abstract]   [Full Text] [Related]  

  • 11. Repurposing drugs targeting metabolic diseases for cancer therapeutics.
    Pillai U J; Ray A; Maan M; Dutta M
    Drug Discov Today; 2023 Sep; 28(9):103684. PubMed ID: 37379903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery.
    Kumar S; Basu M; Ghosh P; Pal U; Ghosh MK
    Genes Dis; 2023 Jul; 10(4):1402-1428. PubMed ID: 37334160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repurposing: An emerging strategy in alleviating skin cancer.
    Kumbhar P; Kole K; Yadav T; Bhavar A; Waghmare P; Bhokare R; Manjappa A; Jha NK; Chellappan DK; Shinde S; Singh SK; Dua K; Salawi A; Disouza J; Patravale V
    Eur J Pharmacol; 2022 Jul; 926():175031. PubMed ID: 35580707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
    Jain P; Jain SK; Jain M
    Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Drugs and Cell Transplantation: More Beneficial Stem Cell-Based Regenerative Therapies Targeting Neurological Disorders.
    Nishimura K; Takata K
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
    Roy S; Dhaneshwar S; Bhasin B
    Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
    Cummings JL; Zhong K
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing drugs to treat cardiovascular disease in the era of precision medicine.
    Abdelsayed M; Kort EJ; Jovinge S; Mercola M
    Nat Rev Cardiol; 2022 Nov; 19(11):751-764. PubMed ID: 35606425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents.
    Zhu S; Bai Q; Li L; Xu T
    Comput Struct Biotechnol J; 2022; 20():2839-2847. PubMed ID: 35765655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
    Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
    Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.